Over 30,000 policies to be transferred that are part of the insurance business acquired by VidaCaixa in November 2022. The total volume of the portfolio, which is no longer open to new business, is €170 million in technical provisions and will provide €10 million in premiums per year. MEDVIDA has reached an agreement with VidaCaixa whereby it...

After signing the sale and purchase agreement last May, MEDVIDA last week received the final regulatory approvals for its acquisition of CNP Partners. The transaction marks an important milestone for MEDVIDA in its long-term strategy to grow and consolidate life insurance operations in Europe. Antonio Trueba, CEO of MEDVIDA, commented: "We have...

MEDVIDA has priced a new issuance of Tier 2 subordinated debt amounting to 21 million euros. The debt is expected to be subscribed for and paid up during December 2022, subject to entering into a subscription agreement and the other agreements relating to the issue, and subject to compliance with the conditions set out in the subscription...

MEDVIDA has successfully issued €30m of subordinated debt maturing in January 2033 to optimise its capital position and support its growth plans including the acquisition of CNPP Partners and the Metropolis life insurance portfolio. Through the issue, MEDVIDA welcomes several new international investors as capital providers. The significant...

The new director of the insurance company was until last June responsible for insurance services at Deloitte Spain and EMEA. MEDVIDA has appointed Jordi Montalbo Todolí, a renowned professional with more than 30 years of experience in the insurance sector, to its board of directors. The new director is an Actuary, has a degree in Economics and...

Metrópolis confirmed yesterday a portfolio transfer of its life insurance business to MEDVIDA. The transaction is subject to regulatory approvals and is expected to be completed by the end of this year. With this transaction, Metrópolis completes its corporate restructuring, ceasing its insurance underwriting activity to focus on its brokerage,...

MEDVIDA has signed terms to acquire CNP Partners, the Spanish subsidiary of the French group CNP Assurances. The sale and purchase agreement was signed today and MEDVIDA is expected to take effective control of CNP Partners in the fourth quarter of 2022, following regulatory approvals. With this acquisition MedVida will double the size of its...